ArticleClinical pharmacology in drug development2014

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vilanterol, a Novel Inhaled Long-Acting β-Agonist, in Children Aged 5-11 Years with Persistent Asthma: A Randomized Trial.

Amanda Oliver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.